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Exposure of A431 human epidermoid carcinoma 
cells to epidermal growth factor (EGF), bradykinin, 
and  histamine  resulted  in a time- and  concentration- 
dependent  accumulation of the inositol  phosphates 
(InsP) inositol monophosphate, inositol  bisphosphate, 
and inositol  trisphosphate  (InsP3).  Maximal  concentra- 
tions of EGF (3 16 ng/ml; -50 nM), bradykinin (1 p ~ ) ,  
and histamine (1 mM) resulted in 3-, 6-, and %fold 
increases,  respectively,  in the  amounts of inositol phos- 
phates  formed over a 10-min period. The KO, values 
for  stimulation  were  approximately 10 nM, 3 nM, and 
10 p~ for EGF, bradykinin, and histamine, respec- 
tively. EGF and  bradykinin  stimulated  the  rapid ac- 
cumulation of the  two isomers of InsP3,  Ins(1,3,4)P3, 
and  Ins(1,4,5)P3 as determined  by  high  performance 
liquid chromatography analysis; maximal accumula- 
tion of Ins(1,4,5)P3 occurred within 15 s. EGF and 
bradykinin also stimulated a rapid (maximal levels 
attained  within 30 s after addition of hormone) and a 
sustained 4- and 6-fold rise, respectively,  in cytosolic 
free Ca2+ levels as measured by Fura-2 fluorescence. 
EGF and  bradykinin also  produced a rapid,  although 
transient, 3- and 5-fold  increase,  respectively,  in  cy- 
tosolic free Ca2+ after chelation of extracellular Ca2+ 
with 3 mM EGTA. These  data are consistent with  the 
idea that EGF elevates intracellular Ca2+ levels in 
A431 cells, at least  in  part, as a result of the  rapid 
formation of Ins(  1,4,5)P3  and  the consequential  release 
of Ca2+ from intracellular stores. 
The EGF’  receptor is a  single-chained,  170,000-dalton 
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transmembrane glycoprotein that possesses intrinsic tyro- 
sine-specific protein  kinase activity (1-5). Activation of the 
EGF receptor initiates a complex series of events  that includes 
the phosphorylation of several protein substrates (6, 7) in- 
cluding autophosphorylation of the receptor (2), a rapid  in- 
ternalization of the  EGF.receptor complex (8, 9), and mito- 
genesis (10).  Because the  products of many oncogenes code 
for tyrosine kinases, including the  v-erb B oncogene which 
codes for a truncated version of the  EGF receptor (3),  many 
studies have focused on  understanding  the  relationship  be- 
tween tyrosine  kinase  activity  and  the  control of cell growth 
and proliferation. However, other biochemical events may be 
important  in  the  action of EGF. For example, activation of 
EGF receptors on A431 human epidermoid carcinoma cells 
has been reported  to  result  in  an i creased rate of radiolabel- 
ing of plasma  membrane phosphoinositides (11,12), including 
PIP  and  PIP,  (13),  the production of diacylglycerol (13),  the 
activation of protein  kinase C (14),  the  uptake of 45Ca2+ (11, 
12), a rapid  but  transient rise in cytoplasmic  Ca2+ (15), and 
the activation of an amelioride-sensitive Na+/H+ exchange 
(13, 16). 
Hormone-stimulated rises in  intracellular Ca2+ concentra- 
tion occur either by influx of extracellular Ca2+ and/or by 
release of stored Ca2+ from intracellular organelles. Only 
limited  information is available on  the molecular mechanisms 
that serve to link the  activation of hormone  receptors to  the 
influx of extracellular Ca2+. In  contrast,  understanding of the 
molecular events underlying hormone-mediated mobilization 
of Ca2+  from  intracellular sources has been  advanced mark- 
edly in recent years. Stimulation of a variety of hormone 
receptors results  in  the  rapid hydrolysis of plasma  membrane 
PIP, to form the two second messengers Ins(1,4,5)P3 and 
diacylglycerol (17). Ins(1,4,5)P3 has been  shown in many 
tissues  to release  Ca2+  from intracellular  stores, most  impor- 
tantly  the endoplasmic reticulum (17).  The occurrence of a 
second InsP, isomer, Ins(1,3,4)P3, has been demonstrated 
recently (18-20), although  the cellular actions, if any, of this 
compound have not been  defined. 
Several recent  reports provide evidence that  activation of 
EGF receptors  does not  stimulate a measurable  accumulation 
of inositol  phosphates  in  BALB/c/3T3 fibroblasts  (21) or a 
measurable  change  in  the radiolabeling of polyphosphoinosi- 
tides  in  rat  hepatocyte  membranes  (22). However, data have 
been reported  that suggest that  EGF  stimulates  the hydrolysis 
of plasma  membrane phosphoinositides to form  inositol phos- 
phates  in A431 cells (11-14), although  this response has  not 
been  shown  directly. To  this  end, we have initiated  studies  to 
determine whether EGF as well as other Ca2+ mobilizing 
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hormones  stimulate  the  formation of inositol  phosphates  in 
A431  cells and to provide a detailed  characterization of the 
inositol  phosphates  formed. We report that EGF, bradykinin, 
and histamine stimulate the rapid accumulation of InsP,, 
InsP2, and InsP3 in A431 cells i n  a time- and concentration- 
dependent manner. Furthermore, data are presented  to show 
that EGF and bradykinin  stimulate  the  rapid  but  transient 
accumulation of both isomers of Inspa, InsP(1,4,5)P3 and 
Ins(1,3,4)P3, and that the observed increases in inositol  phos- 
phate levels i n  response to EGF and bradykinin  are correlated 
with a rapid but transient rise in cytoplasmic Ca2+ in the 
absence of extracellular Ca2+. These data are  consistent  with 
the  idea  that EGF stimulates  the  formation of Ins( 1,4,5)P3 t o  
release Ca2+ from  intracellular  stores  in  A431 cells. 
EXPERIMENTAL  PROCEDURES 
Materials-Dulbecco's  modified  Eagle's  medium, Eagle's minimal 
essential medium, and fetal calf serum were purchased from Grand 
Island Biological Co. (Grand Island, NY). EGF was prepared from 
mouse maxillary glands as described previously (23). Bradykinin was 
purchased from Boehringer Mannheim, and orthophosphoric acid 
(HPLC grade) was purchased from Fisher. Fura-2 and Fura-2-AM 
were obtained from Molecular Probes (Junction City, OR). All other 
reagents, including histamine, EGTA, bovine serum albumin (recrys- 
tallized and lyophilized), lithium chloride, ATP, ADP, AMP, formic 
acid, and ammonium formate were purchased from Sigma. m y ~ - [ ~ H ]  
Inositol (15 Ci/mmol) was obtained from American Radiolabeled 
Chemicals, Inc. (St. Louis, MO), and  my~-[~H]inositol 1,4,5-trisphos- 
phate (1 Ci/mmol) was obtained from Amersham Corp. A431 epider- 
moid carcinoma cells were obtained from the Lineberger Cancer 
Research Center Tissue Culture Facility a t  the University of North 
Carolina, Chapel Hill. 
Cell Cultures"A431 human epidermoid carcinoma cell stock cul- 
tures were maintained at  37 "C in  an 8% COz humidified atmosphere 
in Dulbecco's  modified  Eagle's  medium containing high  glucose  (4500 
mg/liter) supplemented with 5% fetal calf serum and antibiotics. All 
stock plates of cells were confluent and 6-8 days old at  the time of 
subculture. Subculture was accomplished by aspirating the medium 
and detaching the cells by the addition of 3 mM EGTA in isotonic 
NaC1-citrate buffer (pH 7.8) for 30 min. Cells were seeded at a 1:5 
dilution onto 150-mm plastic culture  plates  (Nunc), and  the medium 
was replaced every 4th day. For experiments, cells were routinely 
grown to confluency on 35-mm plastic culture dishes. 
Analysis of Inositol Phosphutes-Confluent cultures of  A431 cells 
were labeled for 24-48 h with 2-3 pCi/ml [3H]inositol in inositol-free 
Dulbecco's  modified Eagle's medium containing high glucose and no 
fetal calf serum. After labeling, the labeling medium  was replaced by 
Eagle's minimal essential medium-HEPES (25 mM) containing 10 
mM LiCl and incubated for 10 min at 37 "C in the presence of room 
air. LiCl was not included in experiments designed to investigate the 
time course of agonist-stimulated accumulation of  InSPa isomers as 
determined by HPLC. Agonists were prepared in a vehicle of the 
same medium containing 0.1% BSA final and added for the indicated 
times, and the reactions were terminated by the addition of 1.0 ml of 
cold 5% trichloroacetic acid. Cells were scraped and collected from 
the dish and  the dish rinsed once with 0.5  ml  of water. The trichlo- 
roacetic acid precipitate was  removed  by centrifugation (4000 X g), 
and  the trichloroacetic acid was extracted from each sample by three 
washes with 2 ml of diethyl ether. Residual ether was removed by 
aspiration and exposure to nitrogen gas. Samples used for HPLC 
analysis of InsP3 isomers were frozen at  -20  'C and saved for analysis 
at a  later time. [3H]Inositol-labeled inositol phosphates in  the aqueous 
sample were determined by anion exchange chromatography as de- 
scribed previously (24). 
Determination of Imp, Isomers by HPLC-InsP3 isomers were 
analyzed by the method of Irvine et al. (19) and  as described previously 
with minor modifications (25). Samples were injected into a  Waters 
HPLC system equipped with a  Whatman  Partisil SAX 10 (4.6 X 250 
mm) anion exchange column equilibrated with Hz0  and maintained 
at a flow rate of 1.25 ml/min. ATP, ADP, and AMP (5 nmol of each) 
were used as UV markers. After the sample was injected, a linear 
gradient of  0-0.7 M ammonium formate (pH 3.7) buffered by  H3PO1 
(AF/P buffer) was eluted over the first 6 min. The concentration of 
AF/P buffer then was increased linearly to 1.8 M until 32 min and 
the elution with 1.8 M buffer maintained until 37 min. Water was 
passed through the column for an additional 8 min before a new 
sample was injected. The eluate containing InsP3 isomers was col- 
lected at 0.3-min intervals. The retention  times of inositol phosphates 
and adenine nucleotides gradually changed after repeated use of the 
HPLC columns. Therefore, the retention  times of adenine nucleotides 
were checked each day prior to injection of radiolabeled inositol 
phosphates, and adenine nucleotides were added to each sample as 
internal  standards. The overall elution profile of 3H-labeled inositol 
compounds isolated from stimulated A431 cells was very similar to 
that previously reported for rat parotid gland (19) and for 1321N1 
human astrocytoma cells (25). The identity of the radiolabeled InsP3 
peaks isolated from A431 cells was verified based on their positions 
relative to AMP, ADP, and ATP as well as the similarity of their 
retention  times with the reported retention times of Ins(1,4,5)P3 (18, 
19,25) and of Ins(1,3,4)P3 (18-20,251. It has been reported previously 
that  hs(1,3,4)P3 coelutes with ATP and  that parotid glands stimu- 
lated with carbachol under the conditions described here predomi- 
nantly  contain Ins(1,3,4)P3 (19). The sixth peak of radioactivity from 
stimulated A431 cells was found to coelute with ATP, with the 
predominant peak from carbachol-stimulated parotid glands, and 
with a retention  time and AF/P concentration consistent with its 
identity as Ins(1,3,4)P3. Irvine et al. (19) reported that Ins(1,4,5)P3 
eluted with a somewhat greater retention time than ATP and 
Ins(1,3,4)P3. Stimulation of erythrocyte ghosts with Ca2+ also pro- 
duces a large amount of Ins(1,4,5)P3 (26). The seventh peak of 
radioactivity from stimulated A431 cells was found to coelute with 
InsPs from Ca2+-stimulated human erythrocyte ghosts and with a 
retention time and AF/P buffer concentration consistent with its 
identity as Ins(1,4,5)P3. Consistent with this conclusion, the seventh 
peak also was found to coelute with authentic [3H]Ins(1,4,5)P3. An 
eighth peak of radioactivity was also observed. Batty et al. (27) 
recently have reported that stimulation of rat cortical slices with 
carbachol results in  the rapid formation of the novel inositol phos- 
phate, inositol (1,3,4,5)-tetrakisphosphate (InSP4). Based on shared 
elution properties off HPLC with a peak enzymatically converted 
from exogenous [3H]Ins(1,4,5)P3,  as described by Nakahata  and 
Harden (25), we have tentatively identified this eighth peak to be 
InSP4. 
Intracellular Calcium Measurements by Fura-,!?-Intracellular Ca2+ 
levels of  A431 cells were measured with the fluorescent Ca2+ indicator 
Fura-2 (28). A431 cells were grown on individual glass coverslips (22- 
mm square, Corning) for 3-4 days to a preconfluent state in medium 
containing 5% fetal calf serum as described above. The cells were 
serum-deprived in the same medium for 24 h, and the serum-free 
medium was replaced with Eagle's minimal essential medium-HEPES 
(25 mm) medium containing no serum. Prior to loading with Fura-2, 
the cells were maintained at  4 "C for 5 min. Preincubation of the cells 
for a brief period at low temperatures was found to reduce signifi- 
cantly the background fluorescence localized to subcellular compart- 
ments as observed by microscopic examination. The cells then were 
placed at room temperature  in the dark and exposed to 1 p~ Fura-2- 
AM for 20 min. Following Fura-2 loading, the cells were rinsed twice 
with phosphate-buffered saline containing HEPES,  the rinse buffer 
was replaced by Eagle's minimal essential medium-HEPES (pH 7.4), 
and  the cells were maintained at approximately 37 "C using an  air 
curtain incubator. Single cells were monitored for their change in 
Fura-2 fluorescence in response to vehicle in the presence or absence 
of drug using digital fluorescence video  microscopy and  the results 
analyzed by digital video image processing as described previously 
(29, 30). Fura-2 fluorescence displays marked Ca2+ sensitivity when 
excited at 340 nm; 380-nm excitation is used to quantitate the 
hydrolyzed Fura-2 pool that is  not Ca2+ bound (28). The ratio of these 
two wavelengths then provides a measure of cytosolic free Caz+ over 
a 25  nM-1 p M  range and corrects for differences in accessible  volume 
or cytoplasmic pathlengths. Following each experiment, changes in 
ratioed Fura-2 fluorescence (340 nM/380  nM)  were calibrated against 
EGTA-buffered solutions containing defined free Cas+ concentrations 
(29). 
RESULTS 
EGF (100  ng/ml; -17 nM), bradykinin (1 pM),  and hista- 
mine (1 mM; data not shown)  each  stimulated a rapid rise in  
the  level of total inositol phosphates, i.e. InsP, + InsP2 + 
InsP,, that was  readily  measurable  within 15 s (Fig. 1). Inositol 
phosphate levels continued to rise for up to  10  min  in the 
presence of each  hormone (data not shown). EGF, bradykinin, 
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(Imp) in the presence of EGF and bradykinin (BK).  A431 cells 
FIG. 1. Time course of accumulation of inositol phosphates 
were grown to confluency and incubated for 2 days with 2 pCi/ml 
were incubated with EGF (O), bradykinin (W), or vehicle (0 ,O)  for 
[3H]inositol in inositol-free medium in the absence of serum. Cells 
the indicated times  in the presence of 10 mM LiCl and were assayed 
for the accumulation of inositol phosphates as described under “Ex- 
perimental Procedures.” Each point represents the mean of three 
dishes & S.E., and  the  data  are representative of three experiments. 
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FIG. 2. Concentration-dependent formation of inositol 
phosphates (ZnsP) by EGF, bradykinin (BK) ,  and histamine 
(HA) in A431 cells. A431 cells were grown to confluency and 
incubated for 2 days with 2 pCi/ml [3H]inositol in inositol-free 
medium in the absence of serum. Cells  were treated with the indicated 
various concentrations of EGF (O), bradykinin (a), or histamine (A) 
for 10 min in the presence of 10 mM LiCl and were assayed for the 
accumulation of inositol phosphates  as described under “Experimen- 
tal Procedures.” The control level of radioactivity accumulated in the 
presence of vehicle (0.1%  BSA) over the same period was 993 & 22 
cpm; this value  was subtracted from each value presented. Eachpoint 
represents the mean of three determinations, and  the  data are rep- 
resentative of three experiments. 
and  histamine  each  increased  inositol  phosphate accumula- 
tion in  a concentration-dependent  manner  with  approximate 
values of 10 nM, 3 nM, and  10 pM, respectively (Fig. 2). 
Exposure of A431 cells to maximal concentrations of EGF 
(316 ng/ml, -50 nM), bradykinin (1 p ~ ) ,  and histamine (1 
mM) for 10 min resulted in a 3-, 6-, and %fold increase, 
respectively, in  the levels of inositol  phosphates (Fig. 2). As 
shown in  Table I, separation of the  hormone-stimulated  ino- 
sitol  phosphates by anion exchange chromatography revealed 
that  EGF,  bradykinin,  and  histamine  each significantly ( p  c 
0.05) increased the levels of InsP1, Inspa, and InsP3 above 
control (vehicle) during a 5-min  stimulation. 
Since EGF was capable of stimulating the formation of 
InsPB  (Table  I)  in A431 cells, it  was important  to  identify  the 
InsP3 products formed. To this end, the HPLC method of 
Irvine et al. (19) was used to separate InsP3 isomers. The 
elution profile  for Ins(1,3,4)P3  and Ins(1,4,5)P3  isolated from 
EGF-  and  bradykinin-stimulated A431 cells is  presented  in 
Fig. 3. Details of the  characterization of these two peaks  as 
Ins(1,3,4)P3 and  Ins( 1,4,5)P3 are described above (see “Exper- 
imental Procedures”). Exposure of A431 cells to  EGF (300 
ng/ml) or bradykinin (1 p ~ )  for 15 s resulted in marked 
increases in  the  amounts of both  Ins(1,4,5)P3  and  Ins(1,3,4)P~. 
The time course for hormone-stimulated accumulation of 
these two isomers is shown in Fig. 4. Maximal levels were 
attained for both  Ins(1,3,4)P3  and Ins(1,4,5)P3 within 15 s. 
Whereas  Ins(  1,4,5)P3 levels returned  to  control  within 5  min 
of exposure to EGF, Ins(1,3,4)P3 levels remained elevated 
over this period (Fig. 4, A and B).  Treatment of A431 cells 
with bradykinin (1 p ~ )  also resulted in a time-dependent 
increase  in  the  amount of each  isomer (Fig. 4, C and D). As 
with the response to EGF, bradykinin-stimulated levels of 
Ins(1,4,5)P3 were maximal  within  15 s and  returned  to  control 
within 5 min.  A peak of radioactivity tentatively identified as 
Ins(1,3,4,5)P4 also was observed to increase in A431 cells in 
response to  EGF  and  bradykinin  (data  not shown). 
Since  EGF  and  braydkinin each stimulated  the  rapid  for- 
mation of Ins(1,4,5)P3, which has been  shown to be a potent 
releasing agent of Ca2+  from intracellular  stores,  it was im- 
portant  to  determine  whether  these two hormones were also 
capable of raising cytosolic Ca2+ levels by mobilizing Caz+  in 
the  absence of extracellular Ca2+. A431 cells were loaded with 
the fluorescent  Ca2+ indicator,  Fura-2,  and  then exposed to 
EGF  or  bradykinin  in  the pr sence or absence of 3 mM EGTA. 
As illustrated  in Fig. 5A, exposure of A431 cells to  EGF (300 
ng/ml) in  the presence of 1.8 mM extracellular Ca2+ resulted 
in a rapid 4- to 5-fold  rise in  intracellular  Ca2+ levels. Maximal 
Ca2+ levels were attained  within 30 s after  addition of EGF, 
and levels remained elevated  for up  to 4 min (Fig. 5A) .  In  the 
presence of 3 mM EGTA  in  the  extracellular medium, EGF 
also elicited a rapid 3- to 4-fold rise in  intracellular Ca2+ levels 
with a peak  time of 30 s following the  addition of hormone. 
However, the maximal  rise in cytosolic Ca2+ levels in response 
to  EGF  in  the  presence of 3 mM EGTA was somewhat lower 
than that observed in the presence of extracellular Ca2+. 
Furthermore,  EGF-stimulated elevation of Ca2+ levels in the 
presence of 3 mM EGTA  returned  to baseline  within  4 min, 
in  contrast  to  the elevated levels of Ca2+  maintained in the 
presence of extracellular  Ca2+ over the  same period (Fig. 5A).  
These  data suggest that  the  EGF-stimulated rise in cytosolic 
Ca2+ in A431 cells is composed of both  an  intracellular  and 
an extracellular component. Similar results were obtained 
when A431 cells were incubated with bradykinin (Fig. 5B). 
Exposure of  A431 cells with bradykinin (1 PM) in  the presence 
of 1.8 mM extracellular Ca2+  resulted in a rapid 6-fold rise in 
cytosolic Ca2+ levels. Bradykinin-stimulated levels peaked 
within 30 s and slowly decreased over the  next 3.5 min (Fig. 
5B). In  the presence of 3 mM extracellular EGTA,  bradykinin 
also was capable of rapidly raising  intracellular Ca2+ levels by 
5-fold within 30 s after  the  addition of hormone. However, 
the elevation was usually less than that observed in the 
presence of Caz+,  and hormone-elevated Ca2+ levels returned 
to baseline within 90 s after  the  addition of hormone (Fig. 
5B). Chelation of extracellular Ca2+  with 3 mM EGTA did not 
block EGF-,  bradykinin-,  or  histamine-stimulated accumula- 
tion of inositol  phosphates  (data  not  shown). 
DISCUSSION 
The  present work demonstrates  that  in A431 epidermoid 
carcinoma cells, EGF and other Ca2+ mobilizing hormones 
stimulate  the  rapid  formation of Ins(1,4,5)P3  and a  concomi- 
tant rise in cytosolic Ca2+,  apparently mobilized from  intra- 
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TABLE I
Hormone-stimulated  accumulation of ImpL Impa and Imp3 in A431 cells 
A431  cells  were  labeled overnight  with 3 pCi/ml of [3H]inositol in inositol-free medium in the absence of fetal 
calf  serum.  Cells  were treated with  vehicle  (0.1%  BSA),  EGF,  bradykinin,  or  histamine at the indicated concentra- 
tions for 5 min. Individual  inositol  phosphates were separated and collected  by anion  exchange  chromatography 
as described under "Experimental Procedures." The data are the mean f S.E. of four determinations and are 
representative of three experiments. Initial ( t  = 0) levels of radioactivity,  in  cpm, for InsP,, InsPz, and InsP3 were 
1487 f 187,  771 f 5, and 1894 f 90,  respectively, and were subtracted from the values  presented. 
InsP,  InsPl 
Addition 
InsPI 
cpm k S.E. Control cpm f S.E. Control cpm k S.E. Control 
% % % 
Vehicle  1731 f 280  100  453 f 33 100 117 f 76  100 
EGF  (500 ng/ml) 3239 f 402  187" 1277 f 227  282"  468 f 120 400" 
Histamine (1 mM) 3229 f 239  185"  1373 f 66  303"  708 f 4 605" 
Bradykinin (1 p ~ )  4634 f 432 267"  1341 f 240 296"  765 f 45  653" 
The increase  in  inositol  phosphate  formation  due to hormone  was significantly  greater than control  with p < 
0.05. Statistical analysis of the data was  performed  using a two-tailed Student's t test. 
2400 
I 5 9 13 17 21 
Fraction No. 
FIG. 3. Elution profile of InsPs isomers isolated from A431 
cells. HPLC  elution of [3H]inositol  phosphates and characterization 
of the radioactive peaks as Jns(1,4,5)P3 and Ins(1,3,4)P3 were as 
described  under  "Experimental  Procedures." Data are  presented as 
fractions  collected at 0.3-min  intervals. A431  cells  were  labeled  for 2 
days  with 3 pCi/ml  [3H]inositol  in  inositol-free  medium  in the absence 
of  serum. Top panel, initial (2' = 0) amounts of 3H  radioactivity  in 
the cells were measured (0), or cells were treated with 300 ng/ml 
EGF  for 15 s in the absence of  LiCl (0). Bottom panel, initial (t = 0) 
amounts of 3H radioactivity in the cells  were  measured (O), or  cells 
were treated with 1 p~ bradykinin (BK) for 15 s in the absence of 
LiCl (0). The data are  single determinations and  are  representative 
of  seven experiments. 
cellular  stores. This  conclusion  is  based  on  the  observations 
that  EGF  stimulates  the  accumulation of total  inositol  phos- 
phates  in a time-  and  concentration-dependent  manner,  stim- 
ulates  the  rapid  accumulation of Ins(1,4,5)P3  and  Ins( 1,3,4)P3, 
and  stimulates a rapid,  albeit  transient,  rise  in cytosolic Caz' 
in  the  absence of extracellular Ca2+. Bradykinin produced a 
qualitatively  similar response. 
Previous  findings  with A431 cells indirectly suggested that 
EGF  activates  phospholipase C. Sawyer and Cohen (11) re- 
ported  that  EGF  stimulated  the  incorporation f 3zP and  [3H] 
inositol  into  phosphatidylinositol  and  produced a 10-fold in- 
crease in the 32P labeling of phosphatidic acid. consistent 
with these findings, Smith et al. (12) reported that EGF 
stimulated a  3- to 4-fold increase  in [3H]inositol-labeled phos- 
phatidylinositol  that was accompanied by a 60-70% increase 
in the levels of '*C-labeled diacylglycerol. Macara (13) re- 
ported recently that EGF did increase the turnover of the 
polyphosphoinositides, PIP and PIPz, and  phosphatidic  acid 
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FIG. 4. Time course of EGF and bradykinin receptor-stim- 
ulated accumulation of Ins(1,3,4)Ps and Ins(1,4,5)Ps in A431 
cells. Cells were labeled for 48 h with 3 pCi/ml [3H]inositol in 
inositol-free medium in the absence of serum. The cells were incu- 
bated  with 300  ng/ml  EGF (A and B) or 1 pM bradykinin (C and D) 
for  5-320 s in the absence of  LiCl and were  assayed  for InsP3 isomers 
as  described  under  "Experimental  Procedures."  The  time-dependent 
accumulations  are  presented for Ins(1,4,5)P3  in the presence of EGF 
(0) or vehicle (0) (A) ,  Ins(1,3,4)P3 in the presence of EGF (A) or 
vehicle (A) (B), Ins(1,4,5)P3 in the presence of bradykinin (0) or 
vehicle (0) (C), and Ins(1,3,4)P3 in the presence of bradykinin (A) or 
vehicle (A) (D). Exposure of A431 cells to vehicle (0.1% BSA) for 
times  less than 320 s had no effect on the levels of InsP3 isomers 
(data not  shown). Ins(1,4,5)P3 and Ins(1,3,4)P3 were quantitated by 
pooling the fractions  corresponding to each InsP3 isomer. The data 
are  expressed as the percent of total radioactivity  (cpm)  associated 
with the Ins(1,3,4)P3 and Ins(1,4,5)P3  peaks,  respectively, at t = 0 
(i.e. % basal). Initial values (t = 0; 100%) in cpm were 1488 f 395 
(A), 80 f 7 (B) ,  1585 f 515 (C), and 232 f 25 (D). The data are the 
mean f S.E. of triplicate determinations and are  representative of 
four  experiments. 
as determined  by  nonequilibrium labeling with 32P. In  contrast 
to  the  current work, EGF  had no apparent effect on  inositol 
phosphate levels. However, the  earliest  time  point  measured 
was 2.5 min, and perhaps, based on the response to EGF 
observed in  the  current  study, a measurable  elevation could 
have been observed at earlier times of hormone challenge. 
Alternatively, a different clone of A431 cells may express a 
different  response  to  EGF. 
Several  reports  have  demonstrated  that  EGF  increases  Ca2+ 
fluxes  and cytoplasmic Ca2+ levels in A431 cells. Sawyer and 
Cohen (11) observed, and Macara (13) recently confirmed, 
that  EGF  stimulates  the  rapid  uptake  and  accumulation of 
45Ca2'. These  reports, however, did  not  further  test  the  capac- 
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FIG. 5. Effect of extracellular Caz+ on changes in cytosolic 
free Ca2+ levels in response to EGF and bradykinin in A431 
cells. Cells  were grown on glass  coverslips (22-mm square, Corning) 
and loaded with Fura-2 as described under “Experimental Proce- 
dures.”  Individual  cells were  monitored  for  changes in Fura-2  fluores- 
cence by digital  fluorescence  video  microscopy  and  analyzed by digital 
video image processing as described under “Experimental Proce- 
dures.” A, A431 cells  were treated with 300 ng/ml  EGF in the presence 
chelated by the addition of 3 mM EGTA (pH 7.4, 37 “C) ( 0  n = 3); 
of 1.8 mM extracellular Ca2+ (0; n = 4), or extracellular Ca2+ was 
B,  A431 cells were treated with 1 p~ bradykinin  in the presence of 
extracellular Ca2+ (0; n = 2), or extracellular Ca2+ was chelated by 
the addition of EGTA ( 0  n = 2). The mean (S3.E.) resting level of 
cytosolic Ca2+ was calculated to be 48 k 3 nM (n = 11). 
ity of EGF  to  stimulate a unidirectional 45Ca2+ efflux from 
45Ca2+-preloaded cells or  investigate  the possibility that  EGF 
may mobilize cellular  Ca2+ from  intracellular  as well as extra- 
cellular sources. I t  was recently  demonstrated (15) that  EGF 
stimulates a rapid 2- to 4-fold rise in cytoplasmic  free  Ca2+ 
concentration  in A431 cells as measured by Quin-2  fluores- 
cence. This  EGF-mediated rise in cytoplasmic Ca2+ was not 
observed in  the  absence of extracellular  Ca2+  and was inhib- 
ited by the Ca2+ channel blockers, MnZ+  and La3+. In  contrast, 
we observed an  EGF-stimulated 3-fold increase  in cytoplasmic 
free  Ca2+ levels in  the  absence of extracellular Ca’+. Although 
the work by Moolenaar  and co-workers  (15)  did not include 
an  analysis of the effects of EGF on either inositol lipid 
metabolism  or  inositol  phosphate  formation,  the  authors  pos- 
tulated that perhaps EGF hydrolyzed phosphoinositides to 
form diacylglycerol and  an  inositol  phosphate  that was incap- 
able of stimulating the release of Ca2+ from intracellular 
stores.  In  the cells  used in  the  current  study,  EGF  stimulated 
the  rapid  formation of Ins(1,4,5)P3, a potent releasing agent 
of Ca2+  from intracellular  stores (17). 
The  reasons  for  the  different  results  concerning  the eff cts 
of EGF  on  inositol  phosphate  formation  and  Ca2+ mobiliza- 
tion  in A431 cells are  not clear. However, one possible reason 
may be the existence of multiple clones of A431 cells that 
respond differently to  EGF  and  other  manipulations.  Macara 
(13)  reported  that it was not possible to  measure  intracellular 
Ca2+ concentrations because the A431 clones used did not 
possess  sufficient esterase  activity  to hydrolyze Ca2+  indica- 
tors  such as Quin-2 and  Fura-2.  This  and a previous report 
(15) demonstrated  that  the available A431 clones do possess 
sufficient esterase activity to sequester Fura-2 and Quin-2, 
respectively. The lack of effect of EGF  to  stimulate a  rise in 
cytosolic Ca2+  in  the  absence of extracellular Ca2+ in A431 
cells (15) when measured by Quin-2  remains puzzling. How- 
ever, it  is possible that  the  intracellular  concentration of Quin- 
2 was sufficiently elevated to buffer transient changes in 
intracellular calcium concentrations. Rigorous  comparison of 
the relative capacity of EGF  to increase inositol  phosphate 
accumulation and cytosolic Ca2+ levels in A431 clones ob- 
tained  from different  sources  should resolve this dichotomy. 
The  present  report  that  EGF  stimulates  the  rapid  formation 
of Ins(1,4,5)P3 in A431 cells demonstrates that EGF acts 
differently in these cells than as reported in several other 
tissues. Binding of EGF  to  BALB/c/3T3  fibroblasts resulted 
in mitogenesis without a measurable  increase  in the levels of 
inositol phosphates (21). Similarly, EGF stimulated an in- 
crease in tyrosine kinase activity in  rat liver plasma mem- 
branes  without a measurable  change  in  the radiolabeling of 
membrane polyphosphoinositides (22). The reasons for the 
differences in the action of EGF on inositol phospholipid 
metabolism in A431 cells as compared  to  rat hepatocytes and 
BALB/c/3T3 fibroblasts are unclear. However, A431 cells 
express an  unusually  high number of EGF receptors, 10- to 
100-fold greater  than  other tissues, and  it  is possible that a 
relationship  exists between  receptor number  and  the capacity 
of the  activated receptor to functionally interact  with  phos- 
pholipase C. Alternatively, these observed differences in  the 
action of EGF at different tissues is consistent with the 
possible existence of two subtypes of the  EGF receptor. Irre- 
spective of the reason  for these differences, the  fact  that  EGF 
is capable of stimulating  the  accumulation of inositol phos- 
phates  in A431 cells raises  the possibility that  EGF may also 
interact  with phospholipase  C to  stimulate  the hydrolysis of 
PIP,  in  other tissues. In  fact, we have obtained  preliminary 
data demonstrating  the  ability of EGF  to  stimulate  the  rapid 
formation of inositol  phosphates  in a rat liver epithelial cell 
line.’ 
The  mechanism(s) whereby the  activation of hormone  re- 
ceptors results in the conversion of PIP, to InsP3 has not 
been  defined. Bradykinin  and  histamine have  been  shown to 
stimulate  the  accumulation of InsP3  in several tissues, and 
recent work using washed membranes from  1321N1 human 
astrocytoma cells has shown that carbachol (31),  bradykinin, 
and histamine3 regulate inositol phosphate formation in a 
guanine  nucleotide-dependent  manner.  Studies with a variety 
of other  tissues  and  hormone receptors  also  strongly suggest 
the involvement of a guanine nucleotide  regulatory protein  in 
hormone-stimulated activation of phospholipase C (32-35). 
Consistent  with  this idea is the  recent observation of guanine 
nucleotide-stimulated formation of inositol phosphates in 
washed membrane  preparations  from A431 cells.4 The mech- 
anism(s) whereby EGF  and  other  peptide growth factor  re- 
ceptors  that  are tyrosine-specific protein  kinases,  such as the 
platelet-derived growth factor receptor, regulate the break- 
down of PIP, are undefined; to date, a guanine nucleotide 
regulatory protein  has  not been  implicated. A431 cells should 
provide  a  useful model system  for  comparison of the mecha- 
nisms whereby EGF  and  other  non-tyrosine  kinase receptors 
regulate  phosphoinositide  metabolism and Ca2+  mobilization. 
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